Thrombolytic treatment for acute ischemic stroke: A 2 year-experience at King Chulalongkorn Memorial Hospital

Journal of the Medical Association of Thailand

Volumn 84, Issue SUPPL. 1, 2001, Pages

  Suwanwela, Nijasri Charnnarong ^a   Suwanwela, Nitaya ^a   Janchai, Akkawat ^a   Phanthumchinda, Kammant ^a   Tantivatana, Jarturon ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Acute Ischemic Stroke; Intraarterial Thrombolysis; Intravenous Thrombolysis; Thrombolytic Agent

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BRAIN ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FIBRINOLYTIC THERAPY; HOSPITAL; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; SURVIVAL RATE; THAILAND; TREATMENT OUTCOME;

AGED; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITALS, URBAN; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; THAILAND; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 0035380184     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 1995; 333: 1581-7.
2. Marier JR, Tilley BC, Lu M, Brott T, Lyden P. Earlier treatment associated with better outcome in the NINDS rt-PA Stroke Study. Stroke 1999; 94: 244. Abstract.
3. Hacke W, Kaste M, Fieschi C, et al. for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995; 274: 1017-25.
4. Hacke W, Kaste M, Fieshchi C, et al. for the Second European-Australasian Acute Stroke Study Investigators. Randomized double-blind placebo controlled trial of thrombolytic stroke (ECASS II). Lancet 1998; 352: 1245-51.
5. Clark WM, Wissman S, Albers G, Jhamandas JH, Madden KP, Hamilton S. for the ATLANTIS study investigators recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset JAMA 1999; 282: 2019-26.
6. Furlan AJ, Higashida RT, Wechsler L, Shulz G and the PROACT Investgators. PROACT II: Recombinant pro-urokinase (r-ProUK) in acute cerebral thromboembolism initial trial results. Stroke 1999; 30: 234-9.
7. Lyden P, Brott T, Tilley B, et al. and the NINDS tPA Stroke Study Group. Improved reliability of the NIH Stroke Scale using video training, Stroke 1994; 25: 2220-6.
8. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous rt-PA therapy for ischemic stroke. Stroke 1997; 28: 2109-18.
9. Andrei AV, Demchuk AM, Felberg RA, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke 2000; 31: 610-4.
10. Grotta JC, Alexandrov AV. TPA-associated reperfusion after acute stroke demonstrated by SPECT. Stroke 1998; 29: 429-32.
11. Heiss W-D, Grond M, Thiel A, et al. Tissue at risk of infarction rescued by early reperfusion: a positron emission thrombolysis of acute stroke. J Cereb Blood Flow Metab 1998; 18: 1298-07.
12. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. Malignant middle cerebral artery territory infarction, Clinical course and prognostic signs. Arch Neurol 1996; 53: 309-15.
13. Schellinger PD, Jansen T, Schwabs S, et al. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ische mic stroke with diffusion and perfusion MRI. Stroke 2000; 31: 1318-28.
14. Devuyst G. Is transcranial colour duplex flow imaging of use in selection of patients with acute stroke for thrombolysis. J Neurol Neurosurg Psychiatr 2000; 68: 794.